Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model

An early identification of the tumor response to sorafenib treatment is indispensable for selecting optimal personalized treatment strategies. However, at present, no reliable predictors are clinically available. (18)F-fluorothymidine ((18)F-FLT) positron emission tomography (PET) is used to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: MURAKAMI, MASAHIRO, ZHAO, SONGJI, ZHAO, YAN, YU, WENWEN, FATEMA, CHOWDHURY NUSRAT, NISHIJIMA, KEN-ICHI, YAMASAKI, MASAHIRO, TAKIGUCHI, MITSUYOSHI, TAMAKI, NAGARA, KUGE, YUJI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789029/
https://www.ncbi.nlm.nih.gov/pubmed/24137387
http://dx.doi.org/10.3892/ol.2013.1459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789029/
https://www.ncbi.nlm.nih.gov/pubmed/24137387
http://dx.doi.org/10.3892/ol.2013.1459

Ejemplares similares